drugset
drugset / Trial / NCT05818553

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

NCT05818553 ↗

Phase 2/3 Active not recruiting 77 enrolled Praxis Precision Medicines
RandomizedParallel-groupTriple-blindTreatment

Summary

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Timeline

Start
2023-08-02
Primary completion
2025-11-12
Completion
2027-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject PRAX-562 Unknown 0.5 mg/kg Oral
Subject PRAX-562 Unknown 1 mg/kg Oral

Indications

genetic developmental and epileptic encephalopathy